US Patent Issued to BIOSYNTH on July 1 for "Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof" (Swiss, Austrian Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,629, issued on July 1, was assigned to BIOSYNTH AG (Staad, Switzerland).

"Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof" was invented by Gunter Schabert (Goldach, Switzerland), Urs Spitz (St. Gallen, Switzerland), Aysel Soydemir (Rorschach, Switzerland) and Iris Zimmermann (Bregenz, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of making nicotinamide ribofuranoside salts, in particular pharmaceutically acceptable nicotinamide ribofuranoside salts. The invention further relates to the nicotinamide ribofuranoside salts as such, in partic...